The COVID-19 pandemic, while demonstrating the nation’s vulnerabilities to biothreats, has also shown the fragility of the supply chain. The United States relies on foreign suppliers for a number of critical components including commodity chemicals, rare earth elements and active pharmaceutical ingredients, she said. Ensuring a resilient domestic supply chain for these components is a…

